Alessandra Bisagni

Reggio Nell'emilia, 42122, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications

CD20-Negative Large B-Cell Lymphomas: The Diagnostic Challenge of Tumors with Downregulation of Mature B-Cell Marker Expression.

CD20-Negative Large B-Cell Lymphomas: The Diagnostic Challenge of Tumors with Downregulation of Mature B-Cell Marker Expression.

Journal: International journal of molecular sciences
Published: July 16, 2025

Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Journal: Cancers
Published: June 11, 2025

Using HistoQC to predict disagreement on human epidermal growth factor receptor 2 (HER2) assessment.

Using HistoQC to predict disagreement on human epidermal growth factor receptor 2 (HER2) assessment.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published: January 23, 2025

Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review.

Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review.

Journal: Current oncology (Toronto, Ont.)
Published: December 10, 2024

A Diagnostic Approach in Large B-Cell Lymphomas According to the Fifth World Health Organization and International Consensus Classifications and a Practical Algorithm in Routine Practice.

A Diagnostic Approach in Large B-Cell Lymphomas According to the Fifth World Health Organization and International Consensus Classifications and a Practical Algorithm in Routine Practice.

Journal: International journal of molecular sciences
Published: November 09, 2024

H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

H3K27me3 Loss in Central Nervous System Tumors: Diagnostic, Prognostic, and Therapeutic Implications.

Journal: Cancers
Published: September 09, 2024

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

Journal: RMD open
Published: June 01, 2024

Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.

Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.

Journal: International journal of molecular sciences
Published: May 19, 2024

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.

Journal: Frontiers in oncology
Published: October 28, 2023

miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.

miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.

Journal: Journal of autoimmunity
Published: September 30, 2023

Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses.

Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses.

Journal: Cancers
Published: July 09, 2023

A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 22, 2023
Showing 1-12 of 63

Last Updated: 09/26/2026